Modiin, Israel

Yitshak Itsik Efrati

This inventor holds 3 USPTO granted patents. Top assignees: Dexcel Ltd., Kitov Pharmaceuticals. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yitshak Itsik Efrati. Retrieved from https://idiyas.com/inventor/yitshak-itsik-efrati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yitshak Itsik Efrati: Innovator in Pharmaceutical Formulations

Introduction

Yitshak Itsik Efrati is a notable inventor based in Modiin, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. With a total of 3 patents to his name, Efrati's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Efrati's latest patents include a formulation and method for combining celecoxib and amlodipine. This innovative composition features granules containing celecoxib, with amlodipine incorporated as an extragranulate. The method of making this composition is also detailed in his patent, showcasing his expertise in pharmaceutical formulation.

Career Highlights

Throughout his career, Efrati has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Dexcel Ltd. and Kitov Pharmaceuticals. His experience in these organizations has contributed to his knowledge and skills in developing effective drug formulations.

Collaborations

Due to space constraints, the details of Efrati's collaborations will not be included.

Conclusion

Yitshak Itsik Efrati is a distinguished inventor whose work in pharmaceutical formulations demonstrates his commitment to advancing medical science. His innovative approaches have the potential to enhance patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…